Embleema

Embleema

Created using Figma

最后更新

2018年10月31日

由于区块链数据安全性和分布功能,您的医疗记录可防篡改并始终可用
您可以选择哪些提供者可以看到您的病史的哪部分,以及您确切地知道谁访问了它以及何时访问它
您的隐私受到符合HIPAA标准的全面保护
Private Sale
10月, 2018
3月, 2019
100% 完成
募集资金 - 无数据
309
目标 20 000 000.00 USD
2 000 000.00 USD
硬帽子 30 000 000.00 USD
past
  • 1 RWD
    =
    0.2 USD
令牌详细信息
断续器
RWD
接受的货币
ETH, BTC, BCH, FIAT
公司详情
注册公司名称
Embleema Inc
注册国家
United States, France
公司成立
Jun 1, 2017
额外细节
MVP /原型
平台
Ethereum
KYC
分类
健康

关于 Embleema

我们相信区块链技术是一种理想的标准,可以为患者,医疗保健专业人员,健康保险支付方和医疗服务提供者提供共享,全面,纵向和可信的病人病史资料。当保存为交易分类帐时,患者的病史明确可由所有利益相关方在患者授权的情况下获得,并且可以确定最佳治疗方案。

PatientTruth&贸易;是一个基于云和区块链的软件解决方案,可连接医院,初级保健实践,康复中心,疗养院和紧急护理中心等不同医疗服务中心的患者不同医疗记录,并将其连接成一致,全面的,防篡改的病史。 PatientTruth及贸易;提供整个供应商和护理中心病人病史的整体视图。

特征

Patients can:

• Register and sign-on through the Patient Dapp interface,

• Upload their health records in the Blockchain, • Visualize their patient record,

• Authorize the sharing of their identified patient record to providers,

• Expose and sell their health records in the Marketplace against RWE tokens,

• Visualize a full audit-trail on their patient record access and health records sold,

• Visualize a statement of his/her RWE transactions.

 

Providers can:

• Register and sign-on through the Provider Dapp interface,

• Visualize an identified patient record, with due consent from the patient,

• Perform a health record quality check, when requested by the health record data owner,

• Visualize a statement of his/her RWE transactions,

 

Care Centers and other Data Owners can:

• Register and sign-on through the Data Owner Dapp interface,

• Have their health records indexed into the Blockchain and linked to patients,

• Expose and sell their health records in the Marketplace against RWE tokens, with due consent from the patients,

• Visualize a statement of RWE transactions,

 

Pharma companies, Payers and other Data Buyers can:

• Register and sign-on through the Data Buyer Dapp interface,

• Expose their inclusion criteria for health record purchases,

• Browse a list of data owners which own health records matching their inclusion criteria,

• Select the data owners they wish to purchase health records from,

• Execute the purchase in RWE tokens with data owners,

• Visualize a statement of RWE transactions,

 

Pharma companies and authorities can:

• Register and sign-on through the Real-World Evidence Dapp interface,

• Pharma companies register health products on which they wish to share with authorities Real-World Evidence, and define the patient records they wish to share,

• Authorities can visualize the shared Real-World Evidence from Pharma companies.

We expect Version 2 to be HIPAA compliant (see “Embleema and Privacy Compliance section” below) for the U.S. users and GDPR compliant for the European users. Version 2 will include health records from U.S. patients. Version 2 is planned to launch in Q3 2019.

技术信息

Embleema Health Blockchain Version 2包含以下功能:


•特定于医疗保健的智能合约管理患者同意,健康记录存储,患者记录存储和共享(已识别和/或去除识别),患者记录访问审计跟踪和
市场,&公牛; Blockchain生成的内置RWE令牌用于交易费用和其他奖励。 RWE令牌交易不需要发送者支付“燃气费”费用,并且具有可预测的挖掘时间,
• API和健康记录解析器集成到区块链中用于健康记录的各种数据格式输入,如HL 7 FHIR,
CCD,专有连接设备格式和其他健康记录格式,&公牛;可扩展性:美国市场上有多达200万患者,
•性能:健康记录的可视化应该在
2秒内进行,区块链中的挖掘应该在5秒内进行,
协调数据购买者与数据所有者的纳入标准
在市场中应该在1分钟内发生,将根据每个数据源的性能评估其他批处理,如数据源解析和索引。

向网络参与者展示的智能合约是:
•健康记录:写下,阅读区块链中的健康记录,
•患者记录:将健康记录连接到给定患者,阅读区块链中的患者记录,
•患者同意:定义患者授权分享他的健康记录(已识别和去识别),
•审计跟踪:为数据所有者提供对其健康记录访问的审计跟踪,
•市场:在患者适当授权后公开数据所有者健康记录元数据,允许数据购买者搜索健康记录进行购买,匹配数据购买者’包含标准
包含数据所有者记录,在数据购买者和数据所有者之间执行购买交易,
• RWE令牌智能合约:发出RWE令牌作为
数据所有者的奖励,用于在区块链中存储健康记录(前3年)

%name%Roadmap

  • Embleema’s growth plan

  • Embleema has already launched the first patient Blockchain.

    Version 1 is publicly accessible at https://patienttruth.embleema.com
    and contains the following functionalities:
    • Upload HL7 Continuity of Care Documents (CCD) medical records
    into blockchain by patients (U.S. patients only),
    • Upload of Fitbit information into blockchain by patients,
    • Consolidation of CCDs (U.S. patients only) and Fitbit information
    into a Medical history stored securely on blockchain,
    • Authorization management from patients for the sharing of their
    Medical history with providers,
    • Visualization by providers of patients’ Medical histories after due
    authorization from patients,
    • Audit-trail for patients of Medical history accesses by providers,
    • Compensation to patients in EBL tokens for uploading CCDs
    (U.S. patients only) and Fitbit information, as well as referrals of
    new patients and providers.

    Version 1 will be used to pilot and prove in real-life the relevance of
    the 2 key concepts carried by the Embleema Health Blockchain:
    • Patients have control of their health records and may share and
    sell their data to pharma companies: this pilot will start in September
    2018 with cysticfibrosis.com, a U.S. based patient community in
    Cystic Fibrosis (announced on July 17, 2018: https://medcitynews.
    com/2018/07/embleema-emerges-from-stealth-mode-launchesblockchain-
    based-health-record-system/),
    • Pharma companies and regulators share the next generation of
    RWE: real-time, individual-patient level 360 view medical histories,
    with continuous monitoring of the same patient and his/her full
    and trusted consent: this pilot will start in January 2019 with
    a top-5 global pharma company and a leading health regulator
    (announcement planned in Q4 2018).
  • End of 2019

  • End of 2019, Embleema expects to expand its Blockchain to the French
    market and the China marketplace with its 800 million connected patient
    population by striking a set of strategic distribution partnerships with major
    local players in the healthcare and technology industry.
  • Q3 2019

  • Concurrently to its V2 launch in Q3 2019, Embleema plans to set up consulting
    services for pharmaceuticals and health network to facilitate the
    adoption of blockchain in their processes and systems.
  • 2021

  • In 2021, Embleema plans to launch V3 of its Health Blockchain Network
    which will able to integrate mining nodes from pharma companies, payers
    and care centers. V3 will also implement an API allowing third party patient
    app providers to connect to the Blockchain and offer personalized services
    to patients through the Blockchain.
  • 阅读更多
  • 2022

  • For 2022, with a critical mass of patient records stored onto the Blockchain,
    Embleema plans to offer advanced analytics services for various purposes:
    population health, observational studies, safety studies. Embleema will also
    start researching the possibility of offering predictive medicine services
    based on the wealth of data stored in the Blockchain.

Embleema 球队

验证 100%

Robert Chu
Founder, CEO and CTO
验证
Prashant Khambekar,...
Chief Blockchain Development Executive
验证
Pradeep Sreekanthan
Chief Delivery Officer
验证
Vincent Galand
Manager, Operations
验证
Pascal Becache
Business Development Executive
验证
Nicolas Schmidt
Chief Product Officer
验证
Alexis Normand
Head of Blockchain Consortium
验证

顾问

验证 29%

注意。未经证实的成员实际上可能不是团队成员

Vahan Simonyan, Phd
Advisor | Chief Scientist - WHISE-Embleema Health...
未验证
Frederic Duchesne, P...
Advisor | CEO of Pierre Fabre Pharmaceuticals
未验证
Atakan Seçkin
Advisor | User Experience
验证
Pr. John Halamka, Md
Advisor | Professor of Innovation at Harvard Medic...
未验证
Adel Al-Saleh
Advisor | CEO of T-Systems and Board Member of Deu...
未验证
Bernard Gilly, Phd
Advisor | CEO at GenSight Biologics & Chairman at...
未验证

2 ICO

$12 158 963

Lorenzo Nardiello
Social Media Manager
验证

Embleema 面试

Atakan Seçkin
As a team member, сan you tell us about your role in the ICO project?
Branding, UI/UX design and implementation of PatientTruth (since POC to product launch) ICO dashboard and future projects
What do you think about idea?
I've designed several products in healthcare industry prior to this project, and none of those projects placed the patient in the center - information asymmetry is a real problem. I believe blockchain with thoughtful design can enable patients to do so much more with their data - not only in terms of being aware, but also the control to choose who can see your data, and monetize it on your own terms and no one else's. We know we have a long road ahead, but I have confidence that we have the best team in the world to be making this product, and we can evolve it in a way that will disrupt existing industries.
Lorenzo Nardiello
As a team member, сan you tell us about your role in the ICO project?
I am in charge of the social media : Telegram, Bitcointalk, Reddit, Discord ... I also organize the bounty program that will come soon and manage our ambassador.
What do you think about idea?
Imagine a world in which you can contribute to medical research and create safer, less expensive and faster new treatments against cancer and rares diseases. Imagine a tamper-proof, holistic, longitudinal and patient-centric worldwide health record interfacing with medical researchers, health regulators, physicians, care centers and the pharmaceutical industry.
Robert Chu
As a team member, сan you tell us about your role in the ICO project?
Founder and CEO of Embleema
I am responsible for overall product strategy, go-to-market and sales of our Embleema Health Blockchain which was launched publicly in July 2018
What do you think about idea?
Embleema Health Blockchain helps patients to advance clinical research by securely sharing their data to pharmaceutical companies during real-world evidence and clinical trial studies. Pharmaceutical companies benefit from faster and more precise data which they can in turn share with regulators such as the U.S. Food and Drug Administration (FDA). Ultimately, patients receive innovative treatments sooner, this is the meaning of our work.
Prashant Khambekar, PhD
As a team member, сan you tell us about your role in the ICO project?
I handle the blockchain development. This includes the ICO/token part.

I also help determine the strategy of the company and its products.
What do you think about idea?
It is a wonderful idea whose time has come. Patients should have the right to control their own health data. The token mechanism helps maintain third-party oversight into the Embleema products.
Pradeep Sreekanthan
As a team member, сan you tell us about your role in the ICO project?
Delivering different versions of the platform. Making the customer experience delightful and easy. Working with various teams.
What do you think about idea?
Revolutionary - bringing healthcare to the blockchain is unusual and will be quite disruptive. RWE in particular.
Vincent Galand
As a team member, сan you tell us about your role in the ICO project?
I am Ops Manager at Embleema Inc. and run Embleema’s ICO operations, coordinating the team of technical experts, legal advisors, social media marketing manager and contractors around the project. I am also developping the business in Europe with pharma companies.
What do you think about idea?
I believe blockchain’s decentralisation power will disrupt the healthcare industry allowing everyone to participate to the advancement of medical progresses. Moreover, we developped a real, concrete industrial use case of Blockchain technology to accelerate medical research, e.g. Real World Evidence / Phase IV clinical trials. We are the only ICO project with a product already available on the market (PatientTruth), first major clients (Pierre Fabre, Servier, others coming soon) and a full support from the medical research community, the pharmaceutical industry and patient associations.
Pascal Becache
As a team member, сan you tell us about your role in the ICO project?
In France and Europe : Investors relations, business development, relations with Pharma companies. As a former IBM and IMS Health executive, I unveil the value of the patient data blockchain for investors, pharmaceutical companies, public and private health insurances and regulators.
What do you think about idea?
Embleema is the future of medical, drugs and population health studies. It will disintermediate collection and use of health data, allowing more, faster, cheaper and more ethical and transparent research benefiting to patients and healthcare systems. It complies with all regulatory aspects in the countries they enter.
Nicolas Schmidt
As a team member, сan you tell us about your role in the ICO project?
I'm Chief Product Officer at Embleema: I lead of our next product development, translate users and customers' needs into a world-class product and manage our marketing.
What do you think about idea?
We're the only healthcare project with a blockchain solution in production, valuable data on usage, several pharma companies as customers and a team of world-class advisors. We achieved all of this before launching our ICO in order to reduce risks for potential subscribers.
Alexis Normand
As a team member, сan you tell us about your role in the ICO project?
I bring together patient advocacy groups & life sciences researchers and regulatoirs to create a decentralized marketplace for health data, to replace the slow, manual and costly process of collecting real world evidence (RWE) for late stage clinical research
What do you think about idea?
Allowing patients to opt-in to pharma research along their own terms is game changing. Only blockchain allows patients to assemble the full picture of their health data, own and share it, and be compensated for their active involvement in clinical research.

Embleema 最新消息

  • 由于信息更新可能存在时间差异,因此应通过其官方网站或其他沟通渠道验证有关每个ICO项目的准确信息。
  • 这些信息不是投资ICO资金的建议或建议。请自行彻底调查相关信息并决定ICO的参与情况。
  • 如果您认为有任何问题需要纠正,或者您想提交自己的ICO项目,请给我们发送电子邮件。
请阅读免责声明和风险警告。 显示免责声明和风险警告。